CD73-INHIBITOREN
European patent · EP3843714 · In force
Register entry
- Publication number
- EP3843714
- Application number
- EP19854871
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Aug 26, 2019
- Published
- Jul 7, 2021
- Granted
- Nov 12, 2025
- Protection ends at the latest
- Aug 25, 2039
- Next annual fee due
- Aug 31, 2026
- IPC classes
- C07D 401/14 (2006.01)A61K 31/115 (2006.01)A61K 31/13 (2006.01)A61K 31/662 (2006.01)C07D 403/14 (2006.01)C07D 403/04 (2006.01)C07D 405/14 (2006.01)C07D 413/14 (2006.01)A61P 35/00 (2006.01)A61P 37/00 (2006.01)
- Priority
- US 201862723271 P 27.08.2018
- PCT application
- PCT/US2019/048141 26.08.2019
- PCT publication
- WO2020/046813 05.03.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 23, 2026
Change
Published in Swissreg on 23.09.2026
- Nov 12, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 12.11.2025
Parties
Inventor
San Mateo, California 94403, US
San Francisco, California 94110, US
Union City, California 94587, US
Fremont, California 94538, US
Union City, California 94587, US
Oakland, California 94619, US
Oakland, California 94618, US
San Francisco, California 94117, US
Dublin, California 94568, US
Fremont, California 94539, US
Fremont, California 94536, US
Pacifica, California 94044, US
Union City, California 94587, US
San Jose, California 95136, US
Foster City, California 94404, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.